2023 PreprintHelp me understand this report
Supplementary Figures from Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies
Abstract: <p>Supplementary Figures S1-S9 show CD32b mRNA vs protein expression, preclinical activity of NVS32b1 vs NVS32b2, differential activation of human vs mouse FcgRs, CD32b expression on cell lines and healthy immune cells.</p>
View published versions
This publication either has no citations yet, or we are still processing them
Set email alert for when this publication receives citations?
See others like this or search for similar articles
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
